GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,442.40+8.20 (+0.57%)
As of 4:04PM BST. Market open.
| Previous close | 1,434.20 |
| Open | 1,442.00 |
| Bid | 1,442.20 x 0 |
| Ask | 1,443.20 x 0 |
| Day's range | 1,422.40 - 1,486.20 |
| 52-week range | 1,190.80 - 1,528.80 |
| Volume | 6,211,333 |
| Avg. volume | 6,720,215 |
| Market cap | 72.578B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 16.62 |
| EPS (TTM) | 86.80 |
| Earnings date | 27 Oct 2021 |
| Forward dividend & yield | 0.80 (5.62%) |
| Ex-dividend date | 19 Aug 2021 |
| 1y target est | 1,584.17 |
- Yahoo Finance UK
GSK Q3 results beat expectations as it gears up to sell consumer healthcare unit
Group turnover was up by 5% to £9.07bn.
- The Independent
Drugs and vaccines help pharma giant GSK beat expectations
The company revealed that turnover grew by 5% to £9.1 billion in the third quarter, surpassing an analyst consensus of around £8.7 billion.
- Zacks
Glaxo (GSK) to Report Q3 Earnings: What's in the Cards?
Glaxo's (GSK) newer respiratory and HIV drugs are likely to have driven third-quarter sales. Although sales of vaccines are likely to have recovered, the impact of the COVID-19 vaccine prioritization may have continued.
© 2021 Verizon Media. All rights reserved.
